Advertisement
Screener

Codiak BioSciences, Inc. Restructuring Charges

Codiak BioSciences, Inc. Restructuring Charges

Codiak BioSciences, Inc. reported Restructuring Charges of $700.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.

Discontinued › Expense Statement › Operating Expenses

us-gaap:RestructuringCharges · last filed 2022-11-03

  • Codiak BioSciences, Inc. restructuring charges for the quarter ending 2022-09-30 was $700.00K.
Period endRestructuring Charges 3 monthRestructuring Charges 9 month
2022-09-30$700.00K
10-Q · filed 2022-11-03
$651.00K
10-Q · filed 2022-11-03